GET THE APP

Exploring 3D structure of human gonadotropin hormone receptor at antagonist state using homology modeling, molecular dynamic simulation, and cross-docking studies
..

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Exploring 3D structure of human gonadotropin hormone receptor at antagonist state using homology modeling, molecular dynamic simulation, and cross-docking studies


15th Annual European Pharma Congress

May 07-09, 2018 | Frankfurt, Germany

Arash Mehdizadeh, Amirhossein Sakhteman, Minasadat Khoddami, Manica Negahdaripour, Mohsen Tatar and Younes Ghasemi

Shiraz University of Medical Sciences, Iran

Posters & Accepted Abstracts: Pharmaceut Reg Affairs

Abstract :

Human gonadotropin hormone receptor, a G-protein coupled receptor, is the target of many medications used in fertility disorders. Obtaining more structural information about the receptor could be useful in many studies related to drug design. In this study, the structure of human gonadotropin receptor was subjected to homology modeling studies and molecular dynamic simulation within a DPPC lipid bilayer for 100 ns. Several frames were thereafter extracted from simulation trajectories representing the receptor at different states. In order to find a proper model of the receptor at the antagonist state, all frames were subjected to cross-docking studies of some antagonists with known experimental values (Ki). Frame 194 revealed a reasonable correlation between docking calculated energy scores and experimental activity values (|r|=0.91). The obtained correlation was validated by means of stratum-specific likelihood ratios (SSLR) and showed the presence of no chance correlation for the obtained model. Different structural features reported for the receptor, such as two disulfide bridges and ionic lock between GLU90 and LYS 121 were also investigated in the final model. Mehdizade_arash@yahoo.com

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward